Polymer derivative of macrolide immunosuppressant
AssigneeNippon Kayaku Kabushiki Kaisha
InventorsNao Yoneki, Akihiro Sekiguchi, Kana Mizunuma, Yuki Kobayashi, Junpei Konno, Kan Saiga, Keiichirou Yamamoto
Life of this patent
Estimating the term…
Loading patent…
AssigneeNippon Kayaku Kabushiki Kaisha
InventorsNao Yoneki, Akihiro Sekiguchi, Kana Mizunuma, Yuki Kobayashi, Junpei Konno, Kan Saiga, Keiichirou Yamamoto
Estimating the term…
An object of the invention is to obtain a preparation which shows enhanced effectiveness and safety compared to tacrolimus, has the concentration in blood maintained at a constant level without individual differences, whereby the control of the amount of administration depending on the blood kinetics (blood trough concentration) becomes unnecessary. The present invention relates to a polymeric derivative of tacrolimus, in which a polyethylene glycol segment and an alcoholic hydroxy group of tacrolimus are bonded to side-chain carboxy groups of a polyaspartic acid derivative.
A polymeric derivative of tacrolimus, comprising a polyaspartic acid derivative, a polyethylene glycol segment, and tacrolimus,
Dependencies are inferred from the claim text.